However, semaglutide can slow gastric emptying (the rate at which food leaves your stomach), which may slightly affect how your body absorbs certain minerals over time
Tirzepatide (MOUNJARO) is a once-weekly subcutaneous injectable agent first authorized for T2DM and later extended to the management of obesity or overweight with at least one weight-related comorbidity, thereby aligning its therapeutic scope with subcutaneous liraglutide and semaglutide [34,35,36]
Structured meal planning , consistent exercise, adequate sleep, and stress management remain the foundation of weight management even when using the most effective medications available
The incretin effect is exclusively glucose-dependent and critical for the maintenance of glucose homeostasis
Rotate the injection site each week to avoid irritation
However, the present study inadequately addresses the impact of these confounding factors